Stoke Therapeutics Inc (STOK)
14.03
-0.10
(-0.71%)
USD |
NASDAQ |
May 16, 16:00
14.03
0.00 (0.00%)
Pre-Market: 20:00
Stoke Therapeutics Total Liabilities (Quarterly): 64.84M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 64.84M |
| December 31, 2023 | 68.78M |
| September 30, 2023 | 66.89M |
| June 30, 2023 | 66.72M |
| March 31, 2023 | 67.97M |
| December 31, 2022 | 71.22M |
| September 30, 2022 | 73.48M |
| June 30, 2022 | 77.11M |
| March 31, 2022 | 75.96M |
| December 31, 2021 | 21.09M |
| September 30, 2021 | 16.26M |
| Date | Value |
|---|---|
| June 30, 2021 | 9.381M |
| March 31, 2021 | 6.443M |
| December 31, 2020 | 11.85M |
| September 30, 2020 | 7.40M |
| June 30, 2020 | 6.814M |
| March 31, 2020 | 6.499M |
| December 31, 2019 | 4.322M |
| September 30, 2019 | 5.144M |
| June 30, 2019 | 4.836M |
| March 31, 2019 | 3.353M |
| December 31, 2018 | 2.471M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.322M
Minimum
Dec 2019
77.11M
Maximum
Jun 2022
36.65M
Average
18.67M
Median
Total Liabilities (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 9.485M |
| iBio Inc | 24.82M |
| Actinium Pharmaceuticals Inc | 44.50M |
| Lixte Biotechnology Holdings Inc | 0.4628M |
| Fate Therapeutics Inc | 143.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.18M |
| Shareholders Equity (Quarterly) | 140.34M |
| Current Ratio | 5.431 |